Leaflet MOXONIDINA MYLAN 0.3mg film-coated tablets


Indicated for: hypertension

Route of administration: oral

Substance: moxonidine (antihypertensive)

ATC: C02AC05 (Cardiovascular system | Antiadrenergic agents, centrally acting | Imidazoline receptor agonists)

Moxonidine is an antihypertensive medication used for the treatment of essential hypertension. It works by stimulating imidazoline receptors in the brainstem, leading to reduced sympathetic activity and, consequently, lower blood pressure.

The medication is taken orally, usually once daily, with the dose adjusted based on the patient's response. Common side effects include dry mouth, fatigue, dizziness, and drowsiness.

Moxonidine is contraindicated in patients with severe renal impairment, severe bradycardia, or hypersensitivity to the active substance. Its use also requires caution in patients with heart failure.

This medication is an effective option for managing hypertension, helping to reduce the risk of cardiovascular complications.

General data about MOXONIDINA MYLAN 0.3mg

  • Substance: moxonidine
  • Date of last drug list: 01-07-2017
  • Commercial code: W60307002
  • Concentration: 0.3mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 28
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Concentrations available for moxonidine

  • 0.2mg
  • 0.3mg
  • 0.4mg